Achilles Therapeutics plc (ACHL)
NASDAQ: ACHL · Real-Time Price · USD
1.070
0.00 (0.00%)
Nov 21, 2024, 3:48 PM EST - Market closed
Achilles Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 44 | 36 | 37 | 203 | - | - | |
| Market Cap Growth | 12.49% | -1.60% | -81.89% | - | - | - | |
| Enterprise Value | -38 | -97 | -134 | -65 | - | - | |
| Last Close Price | 1.07 | 0.89 | 0.90 | 5.01 | - | - | |
| PB Ratio | 0.43 | 0.25 | 0.19 | 0.70 | - | - | |
| P/TBV Ratio | 0.41 | 0.25 | 0.19 | 0.70 | - | - | |
| Debt / Equity Ratio | 0.04 | 0.03 | 0.04 | 0.04 | 0.08 | 0.00 | |
| Quick Ratio | 4.66 | 8.35 | 10.52 | 14.52 | 11.14 | 26.53 | |
| Current Ratio | 6.04 | 8.57 | 10.93 | 14.90 | 11.30 | 26.72 | |
| Return on Equity (ROE) | -52.12% | -41.05% | -29.26% | -25.52% | -22.84% | -24.54% | |
| Return on Assets (ROA) | -30.17% | -24.60% | -16.56% | -14.95% | -13.01% | -14.45% | |
| Return on Capital (ROIC) | -33.60% | -26.64% | -17.54% | -15.80% | -13.72% | -15.04% | |
| Earnings Yield | -152.12% | -192.15% | -193.18% | -30.04% | - | - | |
| FCF Yield | -136.66% | -181.97% | -32.90% | - | - | |
| Buyback Yield / Dilution | -1.45% | -2.13% | -36.59% | -2587.54% | -66.03% | -18.35% | |
| Total Shareholder Return | -1.45% | -2.13% | -36.59% | -2587.54% | -66.03% | -18.35% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.